LifeMD, Inc. (LFMD)

NASDAQ: LFMD · IEX Real-Time Price · USD
10.28
+0.10 (0.98%)
At close: Mar 28, 2024, 4:00 PM
10.64
+0.36 (3.50%)
After-hours: Mar 28, 2024, 7:55 PM EDT

Total Valuation

LifeMD has a market cap or net worth of $401.83 million. The enterprise value is $387.62 million.

Market Cap 401.83M
Enterprise Value 387.62M

Important Dates

The last earnings date was Monday, March 11, 2024, after market close.

Earnings Date Mar 11, 2024
Ex-Dividend Date n/a

Share Statistics

LifeMD has 40.37 million shares outstanding. The number of shares has increased by 9.45% in one year.

Shares Outstanding 40.37M
Shares Change (YoY) +9.45%
Shares Change (QoQ) +6.58%
Owned by Insiders (%) 19.81%
Owned by Institutions (%) 31.09%
Float 30.97M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 2.63
Forward PS 2.06
PB Ratio 114.63
P/FCF Ratio 1,704.00
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 2.54
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF 1,643.72

Financial Position

The company has a current ratio of 1.23, with a Debt / Equity ratio of 5.40.

Current Ratio 1.23
Quick Ratio 1.10
Debt / Equity 5.40
Debt / EBITDA n/a
Debt / FCF 80.28
Interest Coverage -6.77

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -56.30%
Return on Capital (ROIC) -64.58%
Revenue Per Employee $736,942
Profits Per Employee -$114,504
Employee Count 207
Asset Turnover 3.62
Inventory Turnover 5.85

Taxes

In the past 12 months, LifeMD has paid $428,000 in taxes.

Income Tax 428,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +567.53% in the last 52 weeks. The beta is 1.42, so LifeMD's price volatility has been higher than the market average.

Beta (1Y) 1.42
52-Week Price Change +567.53%
50-Day Moving Average 7.65
200-Day Moving Average 6.12
Relative Strength Index (RSI) 61.01
Average Volume (30 Days) 911,965

Short Selling Information

The latest short interest is 1.93 million, so 4.78% of the outstanding shares have been sold short.

Short Interest 1.93M
Short Previous Month 2.73M
Short % of Shares Out 4.78%
Short % of Float 6.24%
Short Ratio (days to cover) 2.58

Income Statement

In the last 12 months, LifeMD had revenue of $152.55 million and -$23.70 million in losses. Loss per share was -$0.70.

Revenue 152.55M
Gross Profit 133.65M
Operating Income -14.49M
Pretax Income -20.17M
Net Income -23.70M
EBITDA -10.97M
EBIT -17.57M
Loss Per Share -$0.70
Full Income Statement

Balance Sheet

The company has $33.15 million in cash and $18.93 million in debt, giving a net cash position of $14.21 million or $0.35 per share.

Cash & Cash Equivalents 33.15M
Total Debt 18.93M
Net Cash 14.21M
Net Cash Per Share $0.35
Equity / Book Value 3.51M
Book Value Per Share 0.09
Working Capital 7.82M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was $8.82 million and capital expenditures -$8.58 million, giving a free cash flow of $235,816.

Operating Cash Flow 8.82M
Capital Expenditures -8.58M
Free Cash Flow 235,816
FCF Per Share $0.01
Full Cash Flow Statement

Margins

Gross margin is 87.61%, with operating and profit margins of -9.50% and -15.54%.

Gross Margin 87.61%
Operating Margin -9.50%
Pretax Margin -13.22%
Profit Margin -15.54%
EBITDA Margin -7.19%
EBIT Margin -11.52%
FCF Margin 0.15%

Dividends & Yields

LifeMD does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -9.45%
Shareholder Yield -9.45%
Earnings Yield -5.90%
FCF Yield 0.06%

Analyst Forecast

The average price target for LifeMD is $12.60, which is 22.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target $12.60
Price Target Difference 22.57%
Analyst Consensus Strong Buy
Analyst Count 5
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on October 14, 2020. It was a reverse split with a ratio of 1:5.

Last Split Date Oct 14, 2020
Split Type Reverse
Split Ratio 1:5

Scores

LifeMD has an Altman Z-Score of 1.2 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.2
Piotroski F-Score 5